Regulatory Affairs provides expertise and support in the conduct of U.S. Food and Drug Administration (FDA)-regulated human subjects research within the Consortium. The program collaborates with other Clinical Research Support areas to provide Consortium investigators and research staff with training, guidance, and tools that enable them to understand and comply with FDA requirements. Requirements may include Investigational New Drug (IND) and Investigational Device Exemption (IDE) regulations, Good Clinical Practice (GCP) and related rules and guidance.
Regulatory Affairs provides guidance and assistance as needed to all Consortium member investigators conducting clinical research under FDA regulations. Support activities further include assisting sponsor-investigators in the preparation and review of regulatory submissions and correspondence with the FDA, related to both clinical research and Expanded Access INDs (also known as single-patient, treatment, or compassionate use INDs). The program also provides hands-on support, coaching, and institutional representation during FDA inspections of Consortium investigators.
Key Contacts
General Inquiries:
RegulatoryAffairs@fredhutch.org
Immediate Notification of FDA Inspection:
Jennifer Davies
Assistant Director, Regulatory Affairs
206-605-1305
jdavies@fredhutch.org
RegulatoryAffairs@fredhutch.org